Serum anti-PDIK1L autoantibody as a novel marker for endometriosis

article OA: bronze CC0 ⤵ 18 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

Researchers investigated serum anti-PDIK1L autoantibody levels and found they may serve as a novel biomarker for diagnosing endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Autoantibodies Endometriosis Protein Serine-Threonine Kinases Uterine Diseases Adolescent Adult Autoantibodies Autoantibodies Biomarkers Biomarkers Biomarkers Carcinoma Carcinoma Carcinoma Case-Control Studies Cells, Cultured Endometriosis Endometriosis Endometriosis Female

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (28)

Cited by (18)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:17:12.951333+00:00
License: CC0 · commercial use OK